These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


405 related items for PubMed ID: 19450671

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI, Kim JC, Kim YH, Tae G, Lee SY, Kim K, Kwon IC.
    J Control Release; 2010 May 10; 143(3):374-82. PubMed ID: 20109508
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
    Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin QR, Kim DD, Chung SJ, Shim CK.
    Int J Pharm; 2009 Apr 17; 371(1-2):142-7. PubMed ID: 19118614
    [Abstract] [Full Text] [Related]

  • 7. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A, Chen J, Liu Y, Deng S, Wu Z, Huang Y, Ping Q.
    Drug Dev Ind Pharm; 2009 Nov 17; 35(11):1348-55. PubMed ID: 19832635
    [Abstract] [Full Text] [Related]

  • 8. Alginate and chitosan particles as drug delivery system for cell therapy.
    Ciofani G, Raffa V, Menciassi A, Dario P.
    Biomed Microdevices; 2008 Apr 17; 10(2):131-40. PubMed ID: 17874301
    [Abstract] [Full Text] [Related]

  • 9. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J, Chen XG, Li YY, Liu CS.
    Nanomedicine; 2007 Dec 17; 3(4):258-65. PubMed ID: 17962086
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
    Shu S, Zhang X, Teng D, Wang Z, Li C.
    Carbohydr Res; 2009 Jul 06; 344(10):1197-204. PubMed ID: 19508912
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development and characterisation of chitosan nanoparticles for siRNA delivery.
    Katas H, Alpar HO.
    J Control Release; 2006 Oct 10; 115(2):216-25. PubMed ID: 16959358
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
    Bravo-Osuna I, Schmitz T, Bernkop-Schnürch A, Vauthier C, Ponchel G.
    Int J Pharm; 2006 Jun 19; 316(1-2):170-5. PubMed ID: 16580797
    [Abstract] [Full Text] [Related]

  • 18. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
    Katas H, Chen S, Osamuyimen AA, Cevher E, Oya Alpar H.
    J Microencapsul; 2008 Dec 19; 25(8):541-8. PubMed ID: 18465303
    [Abstract] [Full Text] [Related]

  • 19. Chitosan nanocapsules: Effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability.
    Santander-Ortega MJ, Peula-García JM, Goycoolea FM, Ortega-Vinuesa JL.
    Colloids Surf B Biointerfaces; 2011 Feb 01; 82(2):571-80. PubMed ID: 21071187
    [Abstract] [Full Text] [Related]

  • 20. Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles.
    Keawchaoon L, Yoksan R.
    Colloids Surf B Biointerfaces; 2011 May 01; 84(1):163-71. PubMed ID: 21296562
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.